Diploma PLC (LON:DPLM) Insider David S. Lowden Purchases 750 Shares

Diploma PLC (LON:DPLM - Get Free Report) insider David S. Lowden purchased 750 shares of the business's stock in a transaction that occurred on Friday, March 21st. The stock was bought at an average cost of GBX 3,928 ($50.57) per share, for a total transaction of £29,460 ($37,929.70).

Diploma Price Performance

Shares of DPLM stock traded up GBX 30 ($0.39) during mid-day trading on Thursday, hitting GBX 4,000 ($51.50). 35,837,938 shares of the stock traded hands, compared to its average volume of 1,101,950. The company's 50-day simple moving average is GBX 4,379.20 and its 200-day simple moving average is GBX 4,376.57. Diploma PLC has a twelve month low of GBX 3,468 ($44.65) and a twelve month high of GBX 4,808 ($61.90). The firm has a market cap of £5.34 billion, a price-to-earnings ratio of 45.98, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17.

Diploma Increases Dividend

The business also recently announced a dividend, which was paid on Friday, January 31st. Stockholders of record on Thursday, January 16th were given a dividend of GBX 42 ($0.54) per share. The ex-dividend date of this dividend was Thursday, January 16th. This is a positive change from Diploma's previous dividend of $17.30. This represents a dividend yield of 0.93%. Diploma's payout ratio is 65.52%.

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. boosted their target price on shares of Diploma from GBX 4,370 ($56.26) to GBX 4,420 ($56.91) and gave the company a "neutral" rating in a research note on Tuesday, January 14th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, Diploma has an average rating of "Moderate Buy" and an average target price of GBX 4,567.50 ($58.81).

Remove Ads

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.